Novel and future treatment strategies

Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review

Standard

Novel and future treatment strategies. / Alhede, Morten; Jakobsen, Tim Holm; Givskov, Michael.

Biofilm Infections. Springer, 2011. p. 231-249.

Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review

Harvard

Alhede, M, Jakobsen, TH & Givskov, M 2011, Novel and future treatment strategies. in Biofilm Infections. Springer, pp. 231-249. https://doi.org/10.1007/978-1-4419-6084-9_14

APA

Alhede, M., Jakobsen, T. H., & Givskov, M. (2011). Novel and future treatment strategies. In Biofilm Infections (pp. 231-249). Springer. https://doi.org/10.1007/978-1-4419-6084-9_14

Vancouver

Alhede M, Jakobsen TH, Givskov M. Novel and future treatment strategies. In Biofilm Infections. Springer. 2011. p. 231-249 https://doi.org/10.1007/978-1-4419-6084-9_14

Author

Alhede, Morten ; Jakobsen, Tim Holm ; Givskov, Michael. / Novel and future treatment strategies. Biofilm Infections. Springer, 2011. pp. 231-249

Bibtex

@inbook{ca008d7c805c4ad0bba06bc1d4dd9287,
title = "Novel and future treatment strategies",
abstract = "The biofilm mode of life is by many scientists acknowledged as a successful, bacterial survival strategy in hostile environments. When bacteria invade their hosts, they encounter harsh conditions such as low levels of iron, oxidative stress, macerating enzymes, phagocytic cells, and host-derived as well as administered antimicrobials. Experimental evidence has accumulated over the years showing that biofilms tolerate antimicrobial properties of the immune system and antibiotics. This multifaceted tolerance relies to a certain extend on general resistance mechanisms including efflux pumps and enzymatic modifications in addition to innate tolerances offered by integral structure-functions of the biofilm.",
author = "Morten Alhede and Jakobsen, {Tim Holm} and Michael Givskov",
year = "2011",
month = dec,
day = "1",
doi = "10.1007/978-1-4419-6084-9_14",
language = "English",
isbn = "9781441960832",
pages = "231--249",
booktitle = "Biofilm Infections",
publisher = "Springer",
address = "Switzerland",

}

RIS

TY - CHAP

T1 - Novel and future treatment strategies

AU - Alhede, Morten

AU - Jakobsen, Tim Holm

AU - Givskov, Michael

PY - 2011/12/1

Y1 - 2011/12/1

N2 - The biofilm mode of life is by many scientists acknowledged as a successful, bacterial survival strategy in hostile environments. When bacteria invade their hosts, they encounter harsh conditions such as low levels of iron, oxidative stress, macerating enzymes, phagocytic cells, and host-derived as well as administered antimicrobials. Experimental evidence has accumulated over the years showing that biofilms tolerate antimicrobial properties of the immune system and antibiotics. This multifaceted tolerance relies to a certain extend on general resistance mechanisms including efflux pumps and enzymatic modifications in addition to innate tolerances offered by integral structure-functions of the biofilm.

AB - The biofilm mode of life is by many scientists acknowledged as a successful, bacterial survival strategy in hostile environments. When bacteria invade their hosts, they encounter harsh conditions such as low levels of iron, oxidative stress, macerating enzymes, phagocytic cells, and host-derived as well as administered antimicrobials. Experimental evidence has accumulated over the years showing that biofilms tolerate antimicrobial properties of the immune system and antibiotics. This multifaceted tolerance relies to a certain extend on general resistance mechanisms including efflux pumps and enzymatic modifications in addition to innate tolerances offered by integral structure-functions of the biofilm.

UR - http://www.scopus.com/inward/record.url?scp=84855884107&partnerID=8YFLogxK

U2 - 10.1007/978-1-4419-6084-9_14

DO - 10.1007/978-1-4419-6084-9_14

M3 - Book chapter

AN - SCOPUS:84855884107

SN - 9781441960832

SP - 231

EP - 249

BT - Biofilm Infections

PB - Springer

ER -

ID: 201670826